Ghent University Academic Bibliography

Advanced

A new discriminative criterion for the development of Franz diffusion tests for transdermal pharmaceuticals

Bram Baert UGent, Jente Boonen UGent, Christian Burvenich UGent, NATHALIE ROCHE UGent, FILIP STILLAERT UGent, Phillip Blondeel UGent, Jan Van Bocxlaer UGent and Bart De Spiegeleer UGent (2010) JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES. 13(2). p.218-230
abstract
PURPOSE. In vitro skin/membrane permeation profiling of topical pharmaceuticals is an important overall quality attribute in the evaluation of product consistency and it is also used for IVIVR (in vitro - in vivo relationship) purposes in product development and change control. Franz diffusion cell (FDC) experiments are emerging as a generally accepted methodology in this field, where the choice of operational conditions requires a data-supported justification towards the discriminating power of the test. A response function is therefore proposed to objectively quantify the discriminating power. METHODS. We evaluated the usefulness of the proposed response function by studying one of the operational conditions, i.e. the influence of receptor medium composition, on the FDC in vitro penetration behaviour of the model compound testosterone formulated in four different topical preparations, using both artificial membranes and dermatomed human skin. A second application is a FDC test system for spilanthol. RESULTS. From the obtained cumulative amount of the active (testosterone or spilanthol) in the receptor fluid versus time curves, the permeability coefficient Kp of the active from each formulation was calculated. The evaluation of the discriminating power of the different media was performed using our new objective response function based upon an equal spread criterion of normalised Kp values. CONCLUSION. The proposed new criterion was found to be useful for the rational design of an in vitro diffusion test for transdermal pharmaceuticals. We demonstrated significant differences in discriminating power between the different media used: (a) for testosterone-containing formulations, it was shown that HPBCD-containing media are more discriminative compared to ethanol- or BSA-containing media; (b) for spilanthol-containing formulations, PBS containing formulations also gave better discriminating results than ethanol-based receptor media.
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
keyword
RISK-ASSESSMENT, PERCUTANEOUS PENETRATION, RELEASE TEST, ALBUMIN, DRUGS, BIOAVAILABILITY, CYCLODEXTRINS, DELIVERY, FLUIDS
journal title
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
J. Pharm. Pharm. Sci.
volume
13
issue
2
pages
218 - 230
Web of Science type
Article
Web of Science id
000281787800001
JCR category
PHARMACOLOGY & PHARMACY
JCR impact factor
1.914 (2010)
JCR rank
145/249 (2010)
JCR quartile
3 (2010)
ISSN
1482-1826
language
English
UGent publication?
yes
classification
A1
copyright statement
I have retained and own the full copyright for this publication
id
1037473
handle
http://hdl.handle.net/1854/LU-1037473
alternative location
http://ejournals.library.ualberta.ca/index.php/JPPS/article/view/6737
date created
2010-09-06 15:34:01
date last changed
2011-07-08 13:44:52
@article{1037473,
  abstract     = {PURPOSE. In vitro skin/membrane permeation profiling of topical pharmaceuticals is an important overall quality attribute in the evaluation of product consistency and it is also used for IVIVR (in vitro - in vivo relationship) purposes in product development and change control. Franz diffusion cell (FDC) experiments are emerging as a generally accepted methodology in this field, where the choice of operational conditions requires a data-supported justification towards the discriminating power of the test. A response function is therefore proposed to objectively quantify the discriminating power. METHODS. We evaluated the usefulness of the proposed response function by studying one of the operational conditions, i.e. the influence of receptor medium composition, on the FDC in vitro penetration behaviour of the model compound testosterone formulated in four different topical preparations, using both artificial membranes and dermatomed human skin. A second application is a FDC test system for spilanthol. RESULTS. From the obtained cumulative amount of the active (testosterone or spilanthol) in the receptor fluid versus time curves, the permeability coefficient Kp of the active from each formulation was calculated. The evaluation of the discriminating power of the different media was performed using our new objective response function based upon an equal spread criterion of normalised Kp values. CONCLUSION. The proposed new criterion was found to be useful for the rational design of an in vitro diffusion test for transdermal pharmaceuticals. We demonstrated significant differences in discriminating power between the different media used: (a) for testosterone-containing formulations, it was shown that HPBCD-containing media are more discriminative compared to ethanol- or BSA-containing media; (b) for spilanthol-containing formulations, PBS containing formulations also gave better discriminating results than ethanol-based receptor media.},
  author       = {Baert, Bram and Boonen, Jente and Burvenich, Christian and ROCHE, NATHALIE and STILLAERT, FILIP and Blondeel, Phillip and Van Bocxlaer, Jan and De Spiegeleer, Bart},
  issn         = {1482-1826},
  journal      = {JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES},
  keyword      = {RISK-ASSESSMENT,PERCUTANEOUS PENETRATION,RELEASE TEST,ALBUMIN,DRUGS,BIOAVAILABILITY,CYCLODEXTRINS,DELIVERY,FLUIDS},
  language     = {eng},
  number       = {2},
  pages        = {218--230},
  title        = {A new discriminative criterion for the development of Franz diffusion tests for transdermal pharmaceuticals},
  url          = {http://ejournals.library.ualberta.ca/index.php/JPPS/article/view/6737},
  volume       = {13},
  year         = {2010},
}

Chicago
Baert, Bram, Jente Boonen, Christian Burvenich, NATHALIE ROCHE, FILIP STILLAERT, Phillip Blondeel, Jan Van Bocxlaer, and Bart De Spiegeleer. 2010. “A New Discriminative Criterion for the Development of Franz Diffusion Tests for Transdermal Pharmaceuticals.” Journal of Pharmacy and Pharmaceutical Sciences 13 (2): 218–230.
APA
Baert, B., Boonen, J., Burvenich, C., ROCHE, N., STILLAERT, F., Blondeel, P., Van Bocxlaer, J., et al. (2010). A new discriminative criterion for the development of Franz diffusion tests for transdermal pharmaceuticals. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 13(2), 218–230.
Vancouver
1.
Baert B, Boonen J, Burvenich C, ROCHE N, STILLAERT F, Blondeel P, et al. A new discriminative criterion for the development of Franz diffusion tests for transdermal pharmaceuticals. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES. 2010;13(2):218–30.
MLA
Baert, Bram, Jente Boonen, Christian Burvenich, et al. “A New Discriminative Criterion for the Development of Franz Diffusion Tests for Transdermal Pharmaceuticals.” JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES 13.2 (2010): 218–230. Print.